> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By Darren Atwater | Sunday 15 July 2018
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
There was a lot of huffing and puffing this week as Forbes magazine published this piece on the business fortunes of 20 year-old American reality TV personality Kylie Jenner. Forbes declares Jenner the worlds youngest self-made billionaire based on the success of her cosmetics company, Kylie Cosmetics.
This billion dollar company as just t seven full-time and five part-time employees, the e-commerce and fulfilment is outsourced to Shopify (NYSE: SHOP) and the manufacturing of the cosmetics are outsourced to Spatz Laboratories, which built its business manufactuing L'Oreal products.
But where had I heard this tiny-business/big-marketcap/outsource-everything from before? It was Steven O'Hara's Optibiotix (OPTI) presentation at the UK Investor Show City Forum last week. During the Q&A, an audience member asked O'Hara how Optibiotix could conduct so much research and business with only six full time employees. O'Hara stated that all the research and development is contracted out, mostly to university labs, to Optibiotix's direction. Let them pay for the overhead and equipment, he believed.
But don't expect O'Hara to star in any ITV (ITV) reality show soon.
* * *
The first non-Tom story is Sunday shocker: I agree with the Wail on Sunday re a 'dark horse' by Chris Bailey at a terrific #2.
* * *
This column itself made it to a terrible #60.
* * *
Our top 10 most-read stories this week were:
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen